10/01/2019 01:38:34

Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cheetah Mobile Inc. Investors

BENSALEM, Pa., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Cheetah Mobile Inc.  (“Cheetah” or the “Company”) (NYSE: CMCM) securities between April 26, 2017 and November 27, 2018, inclusive (the “Class Period”). Cheetah investors have until January 29, 2019 to file a lead plaintiff motion.

Investors suffering losses on their Cheetah investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On November 26, 2018, BuzzFeed News reported that certain Cheetah apps were exploiting user permissions as part of an ad fraud scheme. Specifically, the article claimed that certain Cheetah apps “tracked when users downloaded new apps and used this data to inappropriately claim credit for having caused the download.” On this news, Cheetah’s share price fell $3.32 per share, or nearly 37%, over the next two trading days to close at $5.48 per share on November 27, 2018, thereby injuring investors.

The Complaint filed in this class action alleges that Cheetah, a mobile internet company, made false and/or misleading statements and/or failed to disclose that: (1) Cheetah's mobile apps had embedded features, which were not disclosed, and which tracked when users downloaded new apps; (2) Cheetah improperly used this data to claim credit for having caused the downloads; (3) the foregoing features, when discovered, would foreseeably result in the removal of Cheetah's apps from the Google Play store; (4) the Company's Class Period revenues were in part the product of improper conduct and so unsustainable; and (5) Cheetah's public statements were materially false and misleading at all relevant times.

If you purchased shares of Cheetah, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith

Howard G. Smith, Esquire

215-638-4847

888-638-4847

howardsmith@howardsmithlaw.com

www.howardsmithlaw.com

Related content
25 Feb - 
New Research Coverage Highlights Starbucks, Cheetah Mob..
29 Jan - 
SHAREHOLDER ALERT: MAR CMCM CURO LOMA: The Law Offices ..
29 Jan - 
CLASS ACTION UPDATE for MAR, CMCM, APHA and CURO: Levi ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
REV DEADLINE: Rosen, a Highly Ranked Law Firm, Reminds Revlon, Inc. Investors of Important July 15th Deadline in Securities Class Action – REV
2
Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma
3
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
4
Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress
5
Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual Meeting

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 10:49:11
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB1 - 2019-06-16 11:49:11 - 2019-06-16 10:49:11 - 1000 - Website: OKAY